Antiplatelet and Antithrombotic Activity of RWJ-53308, A Novel Orally Active Glycoprotein IIb/IIIa Antagonist

Author： Damiano B.P. Mitchell J.A. Giardino E. Corcoran T. Haertlein B.J. de Garavilla L. Kauffman J.A. Hoekstra

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.104, Iss.2, 2001-10, pp. : 113-126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet and Antithrombotic Effects of Orbofiban, a New Orally Active GPIIb/IIIa Antagonist, in Guinea Pigs

By Ogawa T. Sugidachi A. Naganuma H. Asai F.

Thrombosis Research, Vol. 97, Iss. 5, 2000-03 ,pp. : 307-315

Elsevier

Access to resources Recommend Favorite

Differential Antiplatelet Effects of Various Glycoprotein IIb-IIIa Antagonists

By Dickfeld

Thrombosis Research, Vol. 101, Iss. 2, 2001-01 ,pp. : 53-64

Elsevier

Access to resources Recommend Favorite

Use of glycoprotein IIb/IIIa receptor antagonist in prosthetic valve thrombosis

By Caceres-Loriga F. Santos-Gracia J.

Platelets, Vol. 21, Iss. 7, 2010-11 ,pp. : 583-583

Informa Healthcare

Access to resources Recommend Favorite

BIOLOGICAL MATRIX-DEPENDENT PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS OF A NOVEL PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR ANTAGONIST, XU063, IN BEAGLE DOGS

By Kapil R.P. Emm T.A. Mousa S.A. Padovani P.K. Quon C.Y. Lam G.N.

Thrombosis Research, Vol. 86, Iss. 3, 1997-05 ,pp. : 221-232

Elsevier

Access to resources Recommend Favorite

Structural Biology of Glycoprotein IIb-IIIa

By Bennett J.S.

Trends in Cardiovascular Medicine, Vol. 6, Iss. 1, 1996-01 ,pp. : 31-36

Elsevier

Access to resources Recommend Favorite